The 20 Best HER-2 Positive Breast Cancer Doctors Near Me in Brighton, MI

Kathleen Kemmer is a Hematologist and an Oncologist practicing medicine in Brighton, Michigan. Dr. Kemmer is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma. Dr. Kemmer is board certified in Medical Oncology.

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.Clinical Specialization:Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma. Dr. Sabel is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Inflammatory Breast Cancer, Mastectomy, and Craniectomy. Dr. Sabel is board certified in Surgery.

University of Texas Southwestern in Dallas, Texas. Her clinical practice has focused on head and neck cancer, lymphoma and hematologic malignancies, CNS malignancies, lung cancer, and breast cancer. However, she is board certified and experienced in treating all disease sites. She has clinical research experience in several disease sites as well, including head and neck cancer, glioblastoma, esophageal cancer, cutaneous lymphoma, and lung cancer. Patient care is her passion, and she enjoys working with patients on a daily basis. She is a strong believer in patient education and making sure patients understand their disease and treatment options. Based on her experience developing clinical trials at Stanford, she is developing an academic program focused on the conduct of clinical trials as well as patient and physician decision-making regarding clinical trials. Her goal is to develop tools to improve clinical trial enrollment through medical team communication as well as patient and physician education. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Intraductal Papilloma.

Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead. He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center. Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT). Dr. Dragovic is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Breast Cancer. Dr. Dragovic is board certified in Radiation Oncology.

Following her undergraduate and graduate studies in Virginia, Dr. Jaworski completed her residency training in Radiation Oncology at the University of Michigan. Dr. Jaworski has closely collaborated with clinical and medical physics faculty members to investigate multiple aspects of radiation treatment planning, including collaborations within the Michigan Radiation Oncology Quality Consortium. Her first-author publications have shown the durable impact of quality measures in reducing the use of prolonged radiation courses for pain relief, gains associated with automated treatment planning for head and neck cancer, and reducing toxicities associated with radiation. As a testament to her passion for patient care and clinical focus, Dr. Jaworski was inducted into the Gold Humanism Honor Society in 2022. Dr. Jaworski is board-eligible and treats all disease sites. Dr. Jaworski is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her clinical expertise encompasses Bone Tumor, Prostate Cancer, HER-2 Positive Breast Cancer, and Endometrial Cancer. Dr. Jaworski is board certified in Radiation Oncology.

Dr Joseph Evans is originally from the Chicago suburbs, and attended the University of Iowa where he graduated with a Bachelor of Science degree in Physics. He then completed the MD-PhD program at Northwestern University Feinberg School of Medicine, where his graduate studies focused on inhibitors of cell death in cancer cells. Dr Evans entered Radiation Oncology at University of Michigan where he completed Residency.Clinically, Dr Evans sees and treats patients with gynecologic cancer, including brachytherapy, spine metastases, and benign diseases treated with radiation treatment, particularly Dupuytren's disease.Dr Evans is a physician leader in the department and the Rogel Cancer Center. He works with other faculty and staff leaders on clinical operations within the department and the interface with the Cancer Center, focusing on process improvement, quality metrics, financial stewardship, and strategy. His work streamlines workflows in the Electronic Medical Record (Epic) to improve patient care, patient experience, and clinician experience. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Prostate Cancer. Dr. Evans is board certified in Radiation Oncology.

John C. Krauss, M.D., graduated from the University of Michigan Medical School in 1985, did his Internal Medicine training at the University of Minnesota, and then returned to the University of Michigan for his Hematology and Oncology specialty training. Dr. Krauss joined the University of Michigan Faculty in 1992, and then moved his research lab to the Cleveland Clinic to continue clinical research on harnessing the immune system to combat cancer. In 1998, Dr. Krauss came back to Ann Arbor to be the Associate Director of the Ann Arbor Community Cancer Oncology Program at St. Joseph Mercy Hospital, and rose through the ranks to be the Section Head of Hematology/Oncology. Dr. Krauss treats a wide variety of patients with cancer, including breast cancer, colon cancer, lung cancer, and kidney cancer, focusing both on providing the highest possible cure rates for cancer and the best quality of life for the patient while on the journey. Dr. Krauss is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Anal Cancer. Dr. Krauss is board certified in Internal Medicine and Medical Oncology.

Lauren M. Perry, MD is an assistant professor in the Division of Surgical Oncology in the Department of Surgery at Michigan Medicine. Dr. Perry is trained in general surgery and specializes in treating patients with breast cancer. She practices at the Rogel Cancer Center, Brighton Center for Specialty Care, and East Ann Arbor Health Center.She earned her medical degree at the Emory University School of Medicine after receiving a merit scholarship. Following her medical education, she completed her general surgery training at the University of California Davis in Sacramento, California. During that time, she received a master's degree in clinical research under an NIH K30 award and was the recipient of a NIH T32 postdoctoral research fellowship in comparative oncology. She then completed her fellowship in breast surgical oncology at Memorial Sloan Kettering Cancer Center in New York City. Dr. Perry is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Li-Fraumeni Syndrome, and HER2 Negative Breast Cancer.

Kimberly Morley is a Hematologist practicing medicine in Brighton, Michigan. Dr. Morley is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Lung Cancer.

Amanda Kupstas is a General Surgeon practicing medicine in Brighton, Michigan. Dr. Kupstas is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Mastectomy.

June Chan M.D. graduated from McGill University with a degree in Honors Physiology in 1991. She then attended Albany Medical College, where she was a member of the Alpha Omega Alpha society in her 3rd year. She completed her Internship training at St. Joseph Mercy Hospital in Ann Arbor, then went on to do her residency training in Radiation Oncology at the University of Michigan, where she was Chief Resident during her final year. As junior faculty, she was awarded an NIH grant to study the use of complementary medicines in cancer patients, and has published papers in the International Journal of Radiation Oncology Biology Physics, and the Journal of Clinical Oncology. Since completing her residency, she has remained on faculty in the Department of Radiation Oncology at the University of Michigan, practicing at our Providence Hospital affiliate. Dr. Chan treats a variety of disease sites including cancers of the breast, lung, head and neck, GI system and brain. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Chan is board certified in Radiation Oncology.

Cynthia Vakhariya is a Hematologist practicing medicine in Novi, Michigan. Dr. Vakhariya is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, Colorectal Cancer, and Bone Marrow Aspiration.

Susan Lyons is a Hematologist and an Oncologist practicing medicine in Novi, Michigan. Dr. Lyons is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 68 other conditions, according to our data. Her clinical expertise encompasses Nasopharyngeal Carcinoma, Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Rajendra Manam is an Oncologist practicing medicine in Novi, Michigan. Dr. Manam is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.

Adam Forman is a Hematologist practicing medicine in Novi, Michigan. Dr. Forman is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Cholangiocarcinoma (Bile Duct Cancer), Paget Disease of the Breast, and Bone Marrow Aspiration.

Cibar Benitez is a Hematologist practicing medicine in Novi, Michigan. Dr. Benitez is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Leo Reap is an Internal Medicine provider practicing medicine in Novi, Michigan. Dr. Reap is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and Thrombocytopenia.

Adeyiza O. Momoh, M.D., James W. Crudup Professor serves as a faculty member in the Section of Plastic Surgery at Michigan Medicine.Dr. Momoh received his BS in Biology from Calvin College and his M.D. degree from Northwestern University School of Medicine. He completed his plastic surgery training at the Baylor College of Medicine, Michael E. DeBakey department of surgery. Following this, he spent a year of fellowship training in microsurgical breast reconstruction and aesthetic breast surgery at the Beth Israel Deaconess Medical Center of Harvard Medical School in Boston, Massachusetts.He is a member of the American Society of Plastic Surgeons, American College of Surgeons, American Society for Reconstructive Microsurgery, Plastic Surgery Research Council, Reed O. Dingman Society, Michigan Academy of Plastic Surgeons, and American Council of Academic Surgeons.Clinical Specialization: Dr. Momoh specializes in all forms of breast reconstruction and has a particular interest in microsurgical breast reconstruction, utilizing a variety of perforator flaps such as the DIEP, SIEA and SGAP flaps. Additional areas of clinical focus include breast augmentation, breast lifts and body procedures for mothers aimed at restoration of form following pregnancy. Dr. Momoh is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Momoh is board certified in Plastic Surgery.

Paige L. Myers, MD, MPH, FACS, serves as a faculty member in the Section of Plastic Surgery at the University of Michigan School of Medicine and is the program director of the Integrated Plastic Surgery Residency. Dr. Myers obtained a Bachelor of Science Degree in Chemistry from Hobart and William Smith College. She then attended Upstate Medical University in Syracuse, NY for her medical degree. She completed a Plastic and Reconstructive Surgery Residency at the University of Rochester. She pursued a fellowship in reconstructive microsurgery at Memorial Sloan Kettering Cancer Center in New York, NY, to provide the most advanced reconstructive techniques to her patients.Clinical Specialization: Dr. Myers specializes in all forms of breast reconstruction, with a particular focus on microsurgical techniques. She has specialized training in using patients' own tissue from the abdomen, thighs, hips, or gluteal region. Additional clinical areas include lymphedema surgery and complex oncologic reconstruction, working closely with the University of Michigan Rogel Cancer Center to provide multidisciplinary, patient-centered care. Her research interests involve investigating the social determinants of health and current policies that affect the delivery of care for breast reconstruction and lymphedema patients. She is also passionate about mentorship and sponsorship in surgery, especially for women and underrepresented minorities. Dr. Myers is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, Breast Cancer, Lymphedema, Mastectomy, and Lymphadenectomy. Dr. Myers is board certified in Plastic Surgery.

Kyle Wilson is a Radiologist and an Interventional Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Wilson is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Budd-Chiari Syndrome, and Cri-Du-Chat Syndrome. Dr. Wilson is board certified in Interventional Radiology & Diagnostic Radiology.